-
-
-
-
-
-
-
ERYTECH Announces Publication of Positive Results from Eryaspase Phase 2 Trial in Hypersensitive ALL in the British Journal of Haematology
-
-
-
-
-
-
-
ERYTECH Announces Presentation of Results of Expanded Access Program in ALL at 2021 ASH Annual Meeting and Acceptance of Two Abstracts at ASCO GI
-
-
-
-
-
-
-
ERYTECH Announces Results from TRYbeCA-1 Phase 3 Trial of Eryaspase in Patients with Second-line Advanced Pancreatic Cancer
-
-
-
-
-
-
-
ERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final Analysis
-
-
-
-
-
-
-
ERYTECH to Present at the JMP Securities Hematology Summit
-
-
-
-
-
-
-
ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2020
-
-
-
-
-
-
-
ERYTECH engages in collaborative partnership with EU Horizon 2020 EVIDENCE consortium
-
976,768 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All